Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome

Manfredi Rizzo, Dragana Nikolic, Esma R. Isenovic, Hanaa S. Sallam, Milan Obradovic, Manfredi Rizzo, Nicola Abate, Manfredi Rizzo, Predrag Bjelogrlic

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)

Abstract

Resistin is an adipocyte- and monocyte-derived cytokine which has been implicated in the modulation of insulin action, energy, glucose and lipid homeostasis. Resistin has been associated with insulin resistance and many of its known complications. As a molecular link between metabolic signals, inflammation, and vascular dysfunction, resistin can be proposed as playing a significant role in the heightened inflammatory state induced by metabolic stress linked to excessive caloric intake, thus contributing to the risk for metabolic syndrome (MetS), type 2 diabetes (T2DM), and cardiovascular diseases (CVD). In this review, we highlighted the role of resistin, as an inflammatory cytokine, in the development of CVD, T2DM and the MetS. © 2014 Bentham Science Publishers.
Original languageEnglish
Pages (from-to)4961-4969
Number of pages9
JournalCURRENT PHARMACEUTICAL DESIGN
Volume20
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome'. Together they form a unique fingerprint.

Cite this